ADVERTISEMENT

Margaret A. Tempero, MD

O-002: Ibrutinib in Combination With Nab-Paclitaxel and Gemcitabine as First-Line Treatment for Patients With Metastatic Pancreatic Adenocarcinoma: Results From the Phase 3 RESOLVE Study

Access the abstract

Jean-Baptiste Bachet ;

Heung-Moon Chang ;

Lisa M. Coussens ;

Lawrence Fong ;

L. Claire Tsao ;

George Cole Jr.;

Danelle James ;

Eric Van Cutsem , MD, PhD;

Margaret A. Tempero , MD;

Teresa Macarulla , MD, PhD;

Josep Tabernero , MD, PhD;

Andrew Hendifar ;

Naureen Starling , MBBS, MD;

Dirk-Thomas Waldschmidt ;

07/31/2019

Debate: Is Adjuvant or Neo-Adjuvant Treatment for Resectable Pancreatic Cancer the Way to Go? - Surgery Plus Adjuvant Chemotherapy

Margaret A. Tempero , MD;

07/19/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement